Logo image of ORIS

ORIENTAL RISE HOLDINGS LTD (ORIS) Stock Fundamental Analysis

NASDAQ:ORIS - Nasdaq - KYG6781A1022 - Common Stock - Currency: USD

0.637  +0.03 (+5.29%)

After market: 0.6171 -0.02 (-3.12%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ORIS. ORIS was compared to 91 industry peers in the Food Products industry. While ORIS has a great health rating, its profitability is only average at the moment. ORIS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ORIS had positive earnings in the past year.
ORIS had a positive operating cash flow in the past year.
ORIS Yearly Net Income VS EBIT VS OCF VS FCFORIS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2M 4M 6M 8M 10M

1.2 Ratios

ORIS has a better Return On Assets (5.93%) than 76.09% of its industry peers.
With a Return On Equity value of 6.10%, ORIS perfoms like the industry average, outperforming 54.35% of the companies in the same industry.
With a Return On Invested Capital value of 4.78%, ORIS perfoms like the industry average, outperforming 53.26% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ORIS is significantly below the industry average of 28.11%.
The 3 year average ROIC (11.00%) for ORIS is well above the current ROIC(4.78%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.93%
ROE 6.1%
ROIC 4.78%
ROA(3y)13.65%
ROA(5y)N/A
ROE(3y)14.57%
ROE(5y)N/A
ROIC(3y)11%
ROIC(5y)N/A
ORIS Yearly ROA, ROE, ROICORIS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of ORIS (18.84%) is better than 96.74% of its industry peers.
In the last couple of years the Profit Margin of ORIS has declined.
With an excellent Operating Margin value of 18.73%, ORIS belongs to the best of the industry, outperforming 94.57% of the companies in the same industry.
ORIS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 29.04%, ORIS is in the better half of the industry, outperforming 64.13% of the companies in the same industry.
ORIS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 18.73%
PM (TTM) 18.84%
GM 29.04%
OM growth 3Y-31.11%
OM growth 5YN/A
PM growth 3Y-30.79%
PM growth 5YN/A
GM growth 3Y-20.11%
GM growth 5YN/A
ORIS Yearly Profit, Operating, Gross MarginsORIS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

ORIS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ORIS has more shares outstanding than it did 1 year ago.
There is no outstanding debt for ORIS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ORIS Yearly Shares OutstandingORIS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
ORIS Yearly Total Debt VS Total AssetsORIS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ORIS has an Altman-Z score of 6.67. This indicates that ORIS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.67, ORIS belongs to the best of the industry, outperforming 89.13% of the companies in the same industry.
ORIS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.67
ROIC/WACC0.63
WACC7.59%
ORIS Yearly LT Debt VS Equity VS FCFORIS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 20M 40M 60M

2.3 Liquidity

ORIS has a Current Ratio of 24.80. This indicates that ORIS is financially healthy and has no problem in meeting its short term obligations.
ORIS has a better Current ratio (24.80) than 100.00% of its industry peers.
A Quick Ratio of 23.79 indicates that ORIS has no problem at all paying its short term obligations.
The Quick ratio of ORIS (23.79) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 24.8
Quick Ratio 23.79
ORIS Yearly Current Assets VS Current LiabilitesORIS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

0

3. Growth

3.1 Past

The earnings per share for ORIS have decreased strongly by -70.76% in the last year.
The earnings per share for ORIS have been decreasing by -26.95% on average. This is quite bad
Looking at the last year, ORIS shows a very negative growth in Revenue. The Revenue has decreased by -42.06% in the last year.
Measured over the past years, ORIS shows a very negative growth in Revenue. The Revenue has been decreasing by -12.44% on average per year.
EPS 1Y (TTM)-70.76%
EPS 3Y-26.95%
EPS 5YN/A
EPS Q2Q%-68.19%
Revenue 1Y (TTM)-42.06%
Revenue growth 3Y-12.44%
Revenue growth 5YN/A
Sales Q2Q%-37.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ORIS Yearly Revenue VS EstimatesORIS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M 20M

4

4. Valuation

4.1 Price/Earnings Ratio

ORIS is valuated cheaply with a Price/Earnings ratio of 2.36.
97.83% of the companies in the same industry are more expensive than ORIS, based on the Price/Earnings ratio.
ORIS is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 2.36
Fwd PE N/A
ORIS Price Earnings VS Forward Price EarningsORIS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ORIS is valued cheaper than 94.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.71
EV/EBITDA -5.41
ORIS Per share dataORIS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ORIS!.
Industry RankSector Rank
Dividend Yield N/A

ORIENTAL RISE HOLDINGS LTD

NASDAQ:ORIS (7/11/2025, 8:00:02 PM)

After market: 0.6171 -0.02 (-3.12%)

0.637

+0.03 (+5.29%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.22%
Inst Owner ChangeN/A
Ins Owners77.23%
Ins Owner ChangeN/A
Market Cap14.02M
AnalystsN/A
Price TargetN/A
Short Float %2.52%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.36
Fwd PE N/A
P/S 0.62
P/FCF 4.71
P/OCF 4.33
P/B 0.2
P/tB 0.2
EV/EBITDA -5.41
EPS(TTM)0.27
EY42.39%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.14
FCFY21.24%
OCF(TTM)0.15
OCFY23.08%
SpS1.03
BVpS3.19
TBVpS3.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.93%
ROE 6.1%
ROCE 6.05%
ROIC 4.78%
ROICexc 12.32%
ROICexgc 12.32%
OM 18.73%
PM (TTM) 18.84%
GM 29.04%
FCFM 13.11%
ROA(3y)13.65%
ROA(5y)N/A
ROE(3y)14.57%
ROE(5y)N/A
ROIC(3y)11%
ROIC(5y)N/A
ROICexc(3y)22.86%
ROICexc(5y)N/A
ROICexgc(3y)22.86%
ROICexgc(5y)N/A
ROCE(3y)14.51%
ROCE(5y)N/A
ROICexcg growth 3Y-34.59%
ROICexcg growth 5YN/A
ROICexc growth 3Y-34.59%
ROICexc growth 5YN/A
OM growth 3Y-31.11%
OM growth 5YN/A
PM growth 3Y-30.79%
PM growth 5YN/A
GM growth 3Y-20.11%
GM growth 5YN/A
F-Score4
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 23.29%
Cap/Sales 1.14%
Interest Coverage 31.04
Cash Conversion 60.36%
Profit Quality 69.6%
Current Ratio 24.8
Quick Ratio 23.79
Altman-Z 6.67
F-Score4
WACC7.59%
ROIC/WACC0.63
Cap/Depr(3y)60.73%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.01%
Cap/Sales(5y)N/A
Profit Quality(3y)117.23%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.76%
EPS 3Y-26.95%
EPS 5YN/A
EPS Q2Q%-68.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.06%
Revenue growth 3Y-12.44%
Revenue growth 5YN/A
Sales Q2Q%-37.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.57%
EBIT growth 3Y-39.69%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.61%
FCF growth 3Y71.83%
FCF growth 5YN/A
OCF growth 1Y-74.39%
OCF growth 3Y-28.66%
OCF growth 5YN/A